Parabilis Medicines, Inc.(PBLS)
Health Care
Biotechnology
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-22 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +244,593 | +0.93%26,529,686 | $28.29 | $6,919,551 | View SEC filing | |
| 2026-06-29 | Soleus Capital, LLC 10% Owner | Purchase | +500,000 | +0.00%652,000 | $20.00 | $10,000,000 | View SEC filing | |
| 2026-06-16 | SEBULSKY ALAN Director | Purchase | +17,500 | +140.00%30,000 | $27.06 | $473,529 | View SEC filing | |
| 2026-06-15 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +21,188,750 | -59.61%2,648,278 | $20.00 | $423,775,000 | View SEC filing | |
| 2026-06-15 | SEBULSKY ALAN Director | Purchase | +12,500 | +100.00%12,500 | $20.00 | $250,000 | View SEC filing |
1-5 of 5